Staphylococcal superantigen‐like protein 3 triggers murine mast cell adhesion by binding to CD43 and augments mast cell activation
Genes to Cells · 2024
DOI: 10.1111/gtc.13111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Sae Kawano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi Prefecture, J…. Hauptthemen laut MEDLINE: Mast Cells, Superantigens, Cell Adhesion, Staphylococcus aureus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: SENSHIN Medical Research Foundation, Koyanagi Foundation, KOSÉ Cosmetology Research Foundation.
Abstract (Originalsprache)
Staphylococcus aureus is a noteworthy pathogen in allergic diseases, as four staphylococcal exotoxins activate mast cells, a significant contributor to inflammation, in an IgE‐independent manner. Although the adhesion of mast cells is an essential process for their immune responses, only a small number of exotoxins have been reported to affect the process. Here, we demonstrated that staphylococcal superantigen‐like (SSL) 3, previously identified as a toll‐like receptor 2 agonist, induced the adhesion of murine bone marrow‐derived mast cells to culture substratum. SSL3‐induced adhesion was mediated by fibronectin in an Arg‐Gly‐Asp (RGD) sequence‐dependent manner, suggesting the integrins were involved in the process. Additionally, SSL3 was found to bind to an anti‐adhesive surface protein CD43. SSL3 induced the adhesion of HEK293 cells expressing exogenous CD43, suggesting that CD43 is the target molecule for adhesion induced by SSL3. Evaluation of SSL3‐derived mutants showed that the C‐terminal region (253–326), specifically T285 and H307, are necessary to induce adhesion. SSL3 augmented the IL‐13 production of mast cells in response to immunocomplex and SSL12. These findings reveal a novel function of SSL3, triggering cell adhesion and enhancing mast cell activation. This study would clarify the correlation between S. aureus and allergic diseases such as atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi Prefecture, Japan.
- Department of Biotechnology, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Nagano Prefecture, Japan.
- Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Nagano Prefecture, Japan.
- Center for Medical Education and Clinical Training, Shinshu University School of Medicine, Matsumoto, Nagano Prefecture, Japan.
- Laboratory of Hygienic Chemistry, Faculty of Pharmaceutical Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa Prefecture, Japan.
ORCID-Profile: Saotomo Itoh, Ryo Suzuki, Shigeaki Hida
Förderung
- SENSHIN Medical Research Foundation
- Koyanagi Foundation
- KOSÉ Cosmetology Research Foundation
- Kobayashi Foundation
- Institute of Drug Discovery Science, Nagoya City University, Japan
- Takeda Science Foundation
- JSPS KAKENHI
Zitieren
APA
Kawano, S., Noda, C., Itoh, S., Urabe, A., Fujii, C., Ogawa, I., Suzuki, R., & Hida, S. (2024). Staphylococcal superantigen‐like protein 3 triggers murine mast cell adhesion by binding to CD43 and augments mast cell activation. Genes to Cells. https://doi.org/10.1111/gtc.13111
Vancouver
Kawano S, Noda C, Itoh S, Urabe A, Fujii C, Ogawa I, et al. Staphylococcal superantigen‐like protein 3 triggers murine mast cell adhesion by binding to CD43 and augments mast cell activation. Genes to Cells. 2024. doi:10.1111/gtc.13111
BibTeX
@article{Kawano2024,
author = {Kawano, Sae and Noda, Chisaki and Itoh, Saotomo and Urabe, Ayaka and Fujii, Chifumi and Ogawa, Isamu and Suzuki, Ryo and Hida, Shigeaki},
title = {Staphylococcal superantigen‐like protein 3 triggers murine mast cell adhesion by binding to CD43 and augments mast cell activation},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13111}
}
EUVIMED